Literature DB >> 15277957

Why the Food and Drug Administration changed the warning label for hetastarch.

Gary R Haynes, Jeana E Havidich, Kim J Payne.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15277957     DOI: 10.1097/00000542-200408000-00055

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  5 in total

1.  The influence of a balanced volume replacement concept on inflammation, endothelial activation, and kidney integrity in elderly cardiac surgery patients.

Authors:  Joachim Boldt; Stephan Suttner; Christian Brosch; Andreas Lehmann; Kerstin Röhm; Andinet Mengistu
Journal:  Intensive Care Med       Date:  2008-09-20       Impact factor: 17.440

2.  Hydroxyethyl starch: the Paradigm of Eminence-Based Versus Evidence-Based Medicine-1.

Authors:  Federico Bilotta; Giovanni Giordano; Fabrizio Caroletti; Francesco Pugliese
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-06-01

3.  Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients.

Authors:  Konrad Reinhart; Anders Perner; Charles L Sprung; Roman Jaeschke; Frederique Schortgen; A B Johan Groeneveld; Richard Beale; Christiane S Hartog
Journal:  Intensive Care Med       Date:  2012-02-10       Impact factor: 17.440

4.  Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients.

Authors:  Franziska Schabinski; Janaina Oishi; Fabio Tuche; Alain Luy; Yasser Sakr; Donald Bredle; Christiane Hartog; Konrad Reinhart
Journal:  Intensive Care Med       Date:  2009-06-17       Impact factor: 17.440

Review 5.  Hydroxyeyhyl starch: Controversies revisited.

Authors:  Rashmi Datta; Rajeev Nair; Anil Pandey; Nitish Gupta; Tapan Sahoo
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.